Biohaven (BHVN) Interest Expenses (2021 - 2026)

Biohaven (BHVN) reported Interest Expenses of $10.9 million for Q1 2026, down 92.04% on a YoY basis from $136.8 million in Q1 2025, and down 82.23% sequentially from $61.3 million in Q3 2025.

Biohaven (BHVN) Interest Expenses (2021 - 2026) Analysis & Trends

Biohaven (BHVN) has 6 years of Interest Expenses data on file, last reported at $10.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Interest Expenses fell 92.04% year-over-year to $10.9 million; the trailing twelve-month figure through Mar 2026 stood at $10.9 million (down 92.04% YoY), and the FY2025 full-year result was $313.4 million, up 3.17% from the prior year.
  • Interest Expenses slipped to $10.9 million in Q1 2026, from $61.3 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $509.3 million in Q1 2024 to a low of $86000.0 in Q3 2023.
  • A 5-year average of $149.8 million and a median of $61.3 million in 2025 frame the typical range for Interest Expenses.
  • Across the five-year window, Interest Expenses plunged 98.64% in 2023 and jumped 496647.67% in 2024, its largest moves.
  • Tracing BHVN's Interest Expenses over 5 years: stood at $216.1 million in 2022, then climbed by 20.08% to $259.4 million in 2023, then increased by 17.07% to $303.7 million in 2024, then sank by 79.81% to $61.3 million in 2025, then tumbled by 82.23% to $10.9 million in 2026.
  • Business Quant data shows BHVN's Interest Expenses at $10.9 million in Q1 2026, $61.3 million in Q3 2025, and $57.1 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -42,141.15
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 100,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 32.89 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 1.17 Bn
10 Biohaven 2.13 Bn 1.78 Bn - 10.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.90 Mn
Mar 31, 2026 10.90 Mn
Sep 30, 2025 61.32 Mn
Sep 30, 2025 61.32 Mn
Jun 30, 2025 57.11 Mn
Jun 30, 2025 57.11 Mn
Mar 31, 2025 136.82 Mn
Mar 31, 2025 136.82 Mn
Dec 31, 2024 303.73 Mn
Dec 31, 2024 303.73 Mn
Sep 30, 2024 427.20 Mn
Sep 30, 2024 427.20 Mn
Jun 30, 2024 256.02 Mn
Jun 30, 2024 256.02 Mn
Mar 31, 2024 509.31 Mn
Mar 31, 2024 509.31 Mn
Dec 31, 2023 259.45 Mn
Dec 31, 2023 259.45 Mn
Sep 30, 2023 86,000.00
Sep 30, 2023 86,000.00